1991
Amersham International acquires I-125 Seeds (now OncoSeed™) from 3M and introduces this prostate cancer treatment in the US market. The proprietary seed delivery system, RapidStrand™, was introduced in the US in 1994.
< Previous Next >
Key:
  The Radiochemical Centre; Amersham International; Nycomed Amersham; Amersham plc
  Nycomed; Nycomed Amersham Imaging; Amersham Health
  Pharmacia; Pharmacia Biotech; Amersham Pharmacia Biotech; Amersham Biosciences

About us - Investors - Our businesses - News & events - Home

© Amersham plc 2003 - All rights reserved. Legal information